Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
2(17%)
Results Posted
50%(1 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
4
33%
Ph phase_2
6
50%
Ph phase_4
1
8%

Phase Distribution

1

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
6(50.0%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(2)
Terminated(2)
Other(6)

Detailed Status

unknown6
Recruiting2
Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 26 (50.0%)
Phase 41 (8.3%)
N/A4 (33.3%)

Trials by Status

unknown650%
recruiting217%
completed217%
terminated217%

Recent Activity

2 active trials
Showing 5 of 12
terminatedphase_1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

NCT05276492
recruitingphase_2

Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial

NCT06700798
completednot_applicable

Short-term Oral Prednisone for Acute Subjective Tinnitus

NCT05591144
recruitingnot_applicable

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

NCT06479304
unknownnot_applicable

Different Dosing Regimens of STOP-AST

NCT06124703
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05276492Phase 1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

Terminated
NCT06700798Phase 2

Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial

Recruiting
NCT05591144Not Applicable

Short-term Oral Prednisone for Acute Subjective Tinnitus

Completed
NCT06479304Not Applicable

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

Recruiting
NCT06124703Not Applicable

Different Dosing Regimens of STOP-AST

Unknown
NCT04492358Phase 2

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Terminated
NCT04810156Phase 2

Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis

Unknown
NCT05167175Phase 2

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Unknown
NCT05129033Not Applicable

A Prospective Study on Optimizing Treatment for ABPA

Unknown
NCT05006664Phase 2

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Unknown
NCT04406376Phase 4

Do We Need to Taper Down Steroid Therapy for Bell's Palsy

Unknown
NCT00633919Phase 2

Efficacy of SLITone in House Dust Mite Allergic Patients

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12